(Q40466654)

20 September 2017

1 reference

title

Health Care Cost-Benefit and Cost-Effectiveness Analysis: An Overview (English)

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

13 July 2024

main subject

cost–benefit analysis

1 reference

2

H. P. Forman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7647430

13 July 2024

author name string

D. Yin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7647430

13 July 2024

language of work or name

1 reference

1 May 1995

1 reference

full work available at URL

20 September 2017

https://api.elsevier.com/content/article/PII:S1051044395728147?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

https://api.elsevier.com/content/article/PII:S1051044395728147?httpAccept=text/plain

13 July 2024

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

Journal of Vascular and Interventional Radiology

13 July 2024

published in

1 reference

20 September 2017

volume

6

1 reference

20 September 2017

issue

3

1 reference

20 September 2017

page(s)

311-320

1 reference

Health care CBA/CEA: an update on the growth and composition of the literature.

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Deliberations on the dissemination of PORT products: translating research findings into improved patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Cost-effectiveness of MR angiography in cases of limb-threatening peripheral vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

An economic study of cost savings on a care-by-parent ward

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The benefit and cost of prostate cancer early detection. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Reducing high blood cholesterol level with drugs. Cost-effectiveness of pharmacologic management

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The cost-effectiveness of replacing high-osmolality with low-osmolality contrast media.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Early prostate cancer: diagnostic costs of screening transrectal US and digital rectal examination

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

A utility-based model for comparing the cost-effectiveness of diagnostic studies

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Cost Effectiveness of Low-Dose Zidovudine Therapy for Asymptomatic Patients with Human Immunodeficiency Virus (HIV) Infection

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Cost effectiveness of chest CT in T1N0M0 lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Safety and cost effectiveness of combined coronary angiography and angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Comparison of costs of new atherectomy devices and balloon angioplasty for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Is bilateral lower extremity compression sonography useful and cost-effective in the evaluation of suspected pulmonary embolism?

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Improved cost allocation in case-mix accounting

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Cost accounting in radiation oncology: a computer-based model for reimbursement

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Eugene W. Caldwell Lecture. Clinical efficacy of diagnostic imaging: love it or leave it.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Guidelines for the clinical and economic evaluation of health care technologies

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Technology assessment: scientific challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Shattuck lecture--outcomes management. A technology of patient experience

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Does free care improve adults' health? Results from a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Measurement of health state utilities for economic appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Willingness to pay and accept risks to cure chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Feasibility of willingness-to-pay measurement in chronic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The Markov process in medical prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The use of a Markov process to simulate and assess follow-up policies for patients with malignant disease: surveillance for stage I nonseminomatous tumors of the testis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The cost-effectiveness of early surgery versus watchful waiting in the management of small abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Simulation modeling and health-care decision making

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Clinical economics. A guide to the economic analysis of clinical practices

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

A clinician's guide to cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Clinical decision making: from theory to practice. Applying cost-effectiveness analysis. The inside story

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

The limits of cost-effectiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1051-0443%2895%2972814-7

7 January 2021

Evaluation and therapy of the patient with fecal occult blood loss: a decision analysis

9

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

Nonionic contrast media: economic analysis and health policy development

13 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

Trans-radial primary percutaneous coronary intervention in dextrocardia using double inversion technique

13 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

The McMaster Health Index Questionnaire as a measure of quality of life for patients with rheumatoid disease

13 July 2024

37

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

Cost-of-illness methodology: a guide to current practices and procedures

13 July 2024

46

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

Medicare to weigh cost as a factor in reimbursement

13 July 2024

57

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(95)72814-7

13 July 2024

Identifiers

1 reference

20 September 2017

1 reference